NAMS MENOPAUSE CERTIFICATION
EXAM COMPREHENSIVE STUDY GUIDE
1. According to the STRAW+10 staging system, which stage represents the late menopausal
transition?
A. Stage -1
B. Stage -2
C. Stage +1a
D. Stage +2
Answer: A
Conceptual Explanation: Stage -1 is the late menopausal transition, characterized by
cycles of amenorrhea lasting 60 days or more, and increasing FSH levels.
2. Which hormone is considered the most sensitive marker for the decline of the ovarian
reserve during the early menopausal transition?
A. Luteinizing Hormone (LH)
B. Estradiol
C. Inhibin B
,D. Progesterone
Answer: C
Conceptual Explanation: Inhibin B levels decline early in the menopausal transition,
preceding the rise in FSH and the drop in estradiol.
3. What is the primary physiological cause of hot flashes (vasomotor symptoms) during
menopause?
A. Excessive progesterone production
B. Increased peripheral vasoconstriction
C. Narrowing of the thermoregulatory zone in the hypothalamus
D. Low levels of thyroid-stimulating hormone
Answer: C
Conceptual Explanation: Vasomotor symptoms are thought to result from a narrowing of
the thermoregulatory set point in the hypothalamus due to estrogen withdrawal.
4. Which of the following is a primary FDA-approved indication for Hormone Therapy (HT)?
A. Prevention of Alzheimer’s disease
B. Treatment of coronary heart disease
C. Improvement of skin elasticity
D. Prevention of postmenopausal osteoporosis
, Answer: D
Conceptual Explanation: NAMS identifies four primary indications for HT: VMS,
prevention of bone loss, hypoestrogenism, and genitourinary symptoms (GSM).
5. A 52-year-old woman with an intact uterus requires HT for severe VMS. Which treatment
regimen is mandatory?
A. Estrogen-only therapy
B. Testosterone-only therapy
C. Progesterone-only therapy
D. Estrogen plus a progestogen
Answer: D
Conceptual Explanation: Women with an intact uterus must receive a progestogen
alongside estrogen to prevent endometrial hyperplasia and cancer.
6. Which findings from the Women’s Health Initiative (WHI) apply to women aged 50-59 using
Estrogen-only therapy?
A. Increased risk of breast cancer
B. Higher mortality rate compared to placebo
C. Significant increase in colorectal cancer
D. Decreased risk of breast cancer and heart disease
Answer: D
EXAM COMPREHENSIVE STUDY GUIDE
1. According to the STRAW+10 staging system, which stage represents the late menopausal
transition?
A. Stage -1
B. Stage -2
C. Stage +1a
D. Stage +2
Answer: A
Conceptual Explanation: Stage -1 is the late menopausal transition, characterized by
cycles of amenorrhea lasting 60 days or more, and increasing FSH levels.
2. Which hormone is considered the most sensitive marker for the decline of the ovarian
reserve during the early menopausal transition?
A. Luteinizing Hormone (LH)
B. Estradiol
C. Inhibin B
,D. Progesterone
Answer: C
Conceptual Explanation: Inhibin B levels decline early in the menopausal transition,
preceding the rise in FSH and the drop in estradiol.
3. What is the primary physiological cause of hot flashes (vasomotor symptoms) during
menopause?
A. Excessive progesterone production
B. Increased peripheral vasoconstriction
C. Narrowing of the thermoregulatory zone in the hypothalamus
D. Low levels of thyroid-stimulating hormone
Answer: C
Conceptual Explanation: Vasomotor symptoms are thought to result from a narrowing of
the thermoregulatory set point in the hypothalamus due to estrogen withdrawal.
4. Which of the following is a primary FDA-approved indication for Hormone Therapy (HT)?
A. Prevention of Alzheimer’s disease
B. Treatment of coronary heart disease
C. Improvement of skin elasticity
D. Prevention of postmenopausal osteoporosis
, Answer: D
Conceptual Explanation: NAMS identifies four primary indications for HT: VMS,
prevention of bone loss, hypoestrogenism, and genitourinary symptoms (GSM).
5. A 52-year-old woman with an intact uterus requires HT for severe VMS. Which treatment
regimen is mandatory?
A. Estrogen-only therapy
B. Testosterone-only therapy
C. Progesterone-only therapy
D. Estrogen plus a progestogen
Answer: D
Conceptual Explanation: Women with an intact uterus must receive a progestogen
alongside estrogen to prevent endometrial hyperplasia and cancer.
6. Which findings from the Women’s Health Initiative (WHI) apply to women aged 50-59 using
Estrogen-only therapy?
A. Increased risk of breast cancer
B. Higher mortality rate compared to placebo
C. Significant increase in colorectal cancer
D. Decreased risk of breast cancer and heart disease
Answer: D
